학술논문

Adjuvant Osimertinib in EGFR-Mutant Early-Stage NSCLC: Does HRQoL Influence Decisions?
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; JUN 1 2022, 28 11, p2204-p2205, 2p.
Subject
Language
English
ISSN
15573265